Rhenman & Partners Asset Management AB as of Dec. 31, 2024
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 92 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 4.1 | $40M | 444k | 89.32 | |
| Eli Lilly & Co. (LLY) | 3.6 | $35M | 46k | 772.00 | |
| Procept Biorobotics Corp (PRCT) | 3.5 | $34M | 420k | 80.52 | |
| Intuitive Surgical Com New (ISRG) | 3.4 | $33M | 64k | 521.96 | |
| Regeneron Pharmaceuticals (REGN) | 3.2 | $31M | 44k | 712.33 | |
| UnitedHealth (UNH) | 3.1 | $31M | 61k | 505.86 | |
| Inspire Med Sys (INSP) | 2.9 | $28M | 150k | 185.38 | |
| Merck & Co (MRK) | 2.8 | $28M | 278k | 99.48 | |
| EXACT Sciences Corporation (EXAS) | 2.7 | $27M | 471k | 56.19 | |
| Tenet Healthcare Corp Com New (THC) | 2.6 | $25M | 198k | 126.23 | |
| Gilead Sciences (GILD) | 2.4 | $24M | 256k | 92.37 | |
| Abbvie (ABBV) | 2.3 | $22M | 124k | 177.70 | |
| Cigna Corp (CI) | 2.2 | $22M | 78k | 276.14 | |
| Medtronic SHS (MDT) | 2.2 | $22M | 270k | 79.88 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $20M | 50k | 402.70 | |
| Alignment Healthcare (ALHC) | 2.0 | $20M | 1.8M | 11.25 | |
| Natera (NTRA) | 2.0 | $20M | 123k | 158.30 | |
| McKesson Corporation (MCK) | 2.0 | $19M | 34k | 569.91 | |
| Biogen Idec (BIIB) | 1.9 | $19M | 124k | 152.92 | |
| Oscar Health Cl A (OSCR) | 1.9 | $18M | 1.4M | 13.44 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.8 | $18M | 146k | 123.15 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $17M | 251k | 65.73 | |
| Royalty Pharma Shs Class A (RPRX) | 1.6 | $15M | 595k | 25.51 | |
| Insulet Corporation (PODD) | 1.5 | $15M | 57k | 261.07 | |
| Intra Cellular Therapies (ITCI) | 1.5 | $15M | 176k | 83.52 | |
| Danaher Corporation (DHR) | 1.5 | $15M | 64k | 229.55 | |
| Abbott Laboratories (ABT) | 1.5 | $15M | 128k | 113.11 | |
| Humana (HUM) | 1.4 | $14M | 55k | 253.71 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $14M | 100k | 136.50 | |
| Zimmer Holdings (ZBH) | 1.3 | $13M | 124k | 105.63 | |
| AmerisourceBergen (COR) | 1.2 | $12M | 54k | 224.68 | |
| CVS Caremark Corporation (CVS) | 1.2 | $12M | 268k | 44.89 | |
| Centene Corporation (CNC) | 1.2 | $12M | 196k | 60.58 | |
| Becton, Dickinson and (BDX) | 1.1 | $11M | 48k | 226.87 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.1 | $11M | 839k | 12.77 | |
| Cooper Cos (COO) | 1.1 | $11M | 115k | 91.93 | |
| Axsome Therapeutics (AXSM) | 1.1 | $10M | 123k | 84.61 | |
| Hca Holdings (HCA) | 1.1 | $10M | 34k | 300.15 | |
| Molina Healthcare (MOH) | 1.0 | $10M | 34k | 291.05 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $9.1M | 1.2M | 7.40 | |
| Janux Therapeutics (JANX) | 0.9 | $9.1M | 170k | 53.54 | |
| Align Technology (ALGN) | 0.9 | $8.7M | 42k | 208.51 | |
| Anthem (ELV) | 0.9 | $8.5M | 23k | 368.90 | |
| Thermo Fisher Scientific (TMO) | 0.8 | $8.1M | 16k | 520.23 | |
| Stryker Corporation (SYK) | 0.8 | $8.1M | 23k | 360.05 | |
| Tg Therapeutics (TGTX) | 0.8 | $7.9M | 263k | 30.10 | |
| Ionis Pharmaceuticals (IONS) | 0.8 | $7.4M | 213k | 34.96 | |
| Cytokinetics Com New (CYTK) | 0.7 | $7.0M | 149k | 47.04 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $6.2M | 196k | 31.91 | |
| Biontech Se Sponsored Ads (BNTX) | 0.6 | $6.0M | 53k | 113.95 | |
| Iqvia Holdings (IQV) | 0.6 | $5.7M | 29k | 196.51 | |
| Nuvalent Inc-a (NUVL) | 0.6 | $5.7M | 73k | 78.28 | |
| Universal Hlth Svcs CL B (UHS) | 0.6 | $5.5M | 31k | 179.42 | |
| Glaukos (GKOS) | 0.6 | $5.5M | 37k | 149.94 | |
| Nurix Therapeutics (NRIX) | 0.6 | $5.5M | 290k | 18.84 | |
| Encompass Health Corp (EHC) | 0.5 | $5.2M | 56k | 92.35 | |
| Xencor (XNCR) | 0.5 | $4.5M | 196k | 22.98 | |
| Novo-nordisk A S Adr (NVO) | 0.4 | $4.3M | 50k | 86.02 | |
| Insmed Com Par $.01 (INSM) | 0.4 | $4.2M | 62k | 69.04 | |
| Esperion Therapeutics (ESPR) | 0.4 | $4.2M | 1.9M | 2.20 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $4.0M | 17k | 235.31 | |
| Krystal Biotech (KRYS) | 0.4 | $3.7M | 24k | 156.66 | |
| Viking Therapeutics (VKTX) | 0.4 | $3.6M | 90k | 40.24 | |
| Immunovant (IMVT) | 0.4 | $3.6M | 145k | 24.77 | |
| Geron Corporation (GERN) | 0.4 | $3.5M | 1.0M | 3.54 | |
| Arcellx Common Stock (ACLX) | 0.3 | $3.3M | 44k | 76.69 | |
| Merus N V (MRUS) | 0.3 | $3.1M | 75k | 42.05 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $3.1M | 232k | 13.22 | |
| Mirum Pharmaceuticals (MIRM) | 0.3 | $3.0M | 74k | 41.35 | |
| Arvinas Ord (ARVN) | 0.3 | $3.0M | 156k | 19.17 | |
| Annexon (ANNX) | 0.3 | $2.8M | 543k | 5.13 | |
| Charles River Laboratories (CRL) | 0.3 | $2.7M | 15k | 184.60 | |
| Kura Oncology (KURA) | 0.3 | $2.7M | 315k | 8.71 | |
| Astrana Health Com New (ASTH) | 0.3 | $2.5M | 80k | 31.53 | |
| Dianthus Therapeutics (DNTH) | 0.3 | $2.5M | 114k | 21.80 | |
| Transmedics Group (TMDX) | 0.2 | $2.4M | 38k | 62.35 | |
| Privia Health Group (PRVA) | 0.2 | $2.4M | 121k | 19.55 | |
| Medpace Hldgs (MEDP) | 0.2 | $2.3M | 6.8k | 332.23 | |
| Alkermes SHS (ALKS) | 0.2 | $2.2M | 78k | 28.76 | |
| Bruker Corporation (BRKR) | 0.2 | $2.1M | 36k | 58.62 | |
| Ideaya Biosciences (IDYA) | 0.2 | $2.1M | 82k | 25.70 | |
| Relay Therapeutics (RLAY) | 0.2 | $1.9M | 460k | 4.12 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $1.7M | 58k | 29.50 | |
| Pliant Therapeutics (PLRX) | 0.2 | $1.5M | 116k | 13.17 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.4M | 35k | 39.20 | |
| Avantor (AVTR) | 0.1 | $1.3M | 62k | 21.07 | |
| Repligen Corporation (RGEN) | 0.1 | $1.3M | 9.0k | 143.94 | |
| Inmune Bio Ord (INMB) | 0.1 | $833k | 178k | 4.67 | |
| Amgen (AMGN) | 0.1 | $782k | 3.0k | 260.64 | |
| Igm Biosciences (IGMS) | 0.1 | $770k | 126k | 6.11 | |
| Acadia Healthcare (ACHC) | 0.1 | $545k | 14k | 39.65 | |
| Bio-techne Corporation (TECH) | 0.0 | $216k | 3.0k | 72.03 |
